MAPT and Alzheimer disease: These results suggested that impaired glucose metabolism leading to reduced O-GlcNAcylation of Tau results in its hyperphosphorylation [3–4 folds more phosphate than normal Tau (Liu et al., 2004)] and neurofibrillary degeneration in AD.